Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178266 | SCV000230313 | uncertain significance | not provided | 2014-12-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000178266 | SCV001121905 | likely benign | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001163234 | SCV001325253 | likely benign | Retinitis pigmentosa | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Ce |
RCV000178266 | SCV004700380 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | RP1: BP4, BS2 |
Prevention |
RCV003895200 | SCV004711117 | likely benign | RP1-related condition | 2019-08-06 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Department of Pathology and Laboratory Medicine, |
RCV001356977 | SCV001552286 | likely benign | Retinitis pigmentosa 1 | no assertion criteria provided | clinical testing | The RP1 p.P1276S variant was identified in a mother and child with familial brain tumors; however, their phenotype was attributed to pathogenic variants in the TP53 and ARTX genes (Nordfors_2018_PMID:29602769). The variant was identified in dbSNP (ID: rs151316028) and ClinVar (classified as likely benign by Illumina and Invitae; and as uncertain significance by EGL Genetic Diagnostics). The variant was identified in control databases in 479 of 282826 chromosomes (2 homozygous) at a frequency of 0.001694, and was observed at the highest allele count in the European (non-Finnish) population in 341 of 129136 chromosomes (freq: 0.002641) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.P1276 residue is not conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) do not suggest a high likelihood of impact to the protein. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. | |
Clinical Genetics, |
RCV000178266 | SCV001920952 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000178266 | SCV001971325 | likely benign | not provided | no assertion criteria provided | clinical testing |